Phenotypic Analysis of Human Lymph Nodes in Subjects With New-Onset Type 1 Diabetes and Healthy Individuals by Flow Cytometry.

Saved in:
Bibliographic Details
Title: Phenotypic Analysis of Human Lymph Nodes in Subjects With New-Onset Type 1 Diabetes and Healthy Individuals by Flow Cytometry.
Authors: Yang JHM; Department of Immunobiology, School of Immunology & Microbial Sciences (SIMS), King's College London, London, United Kingdom.; NIHR Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, United Kingdom., Khatri L; Department of Immunobiology, School of Immunology & Microbial Sciences (SIMS), King's College London, London, United Kingdom.; NIHR Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, United Kingdom., Mickunas M; Department of Immunobiology, School of Immunology & Microbial Sciences (SIMS), King's College London, London, United Kingdom.; NIHR Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, United Kingdom., Williams E; Department of Immunobiology, School of Immunology & Microbial Sciences (SIMS), King's College London, London, United Kingdom.; NIHR Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, United Kingdom., Tatovic D; Diabetes/Autoimmunity Research Group, Cardiff University School of Medicine, Cardiff, United Kingdom., Alhadj Ali M; Diabetes/Autoimmunity Research Group, Cardiff University School of Medicine, Cardiff, United Kingdom., Young P; Public Health Wales, Cardiff, United Kingdom., Moyle P; Experimental Medicine and Immunotherapeutics (EMIT), Department of Medicine, University of Cambridge, Cambridge, United Kingdom., Sahni V; GlaxoSmithKline Medicines Research Centre, Stevenage, United Kingdom., Wang R; GlaxoSmithKline Medicines Research Centre, Stevenage, United Kingdom., Kaur R; GlaxoSmithKline Medicines Research Centre, Stevenage, United Kingdom., Tannahill GM; GlaxoSmithKline Medicines Research Centre, Stevenage, United Kingdom., Beaton AR; GlaxoSmithKline Medicines Research Centre, Stevenage, United Kingdom., Gerlag DM; GlaxoSmithKline Medicines Research Centre, Stevenage, United Kingdom., Savage COS; GlaxoSmithKline Medicines Research Centre, Stevenage, United Kingdom., Napolitano Rosen A; GlaxoSmithKline Medicines Research Centre, Stevenage, United Kingdom., Waldron-Lynch F; Experimental Medicine and Immunotherapeutics (EMIT), Department of Medicine, University of Cambridge, Cambridge, United Kingdom., Dayan CM; Diabetes/Autoimmunity Research Group, Cardiff University School of Medicine, Cardiff, United Kingdom., Tree TIM; Department of Immunobiology, School of Immunology & Microbial Sciences (SIMS), King's College London, London, United Kingdom.; NIHR Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, United Kingdom.
Source: Frontiers in immunology [Front Immunol] 2019 Oct 31; Vol. 10, pp. 2547. Date of Electronic Publication: 2019 Oct 31 (Print Publication: 2019).
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2019.02547